• 1. Emission properties of dye-doped cationic nanoparticles: size, surfactant and monomeric composition effects
  Eduardo Enciso,Luis Cerdán,Leire Gartzia-Rivero,Jorge Ba?uelos,Angel Costela,I?igo López-Arbeloa,Inmaculada García-Moreno RSC Adv., 2015,5, 4454-4462
• 2. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 3. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Emerging investigators
  Polym. Chem., 2015,6, 5501-5502

Ethyl 2-(4-methylthiazol-5-yl)acetate (CAS No. 406727-23-9): A Comprehensive Overview

Ethyl 2-(4-methylthiazol-5-yl)acetate, with the chemical formula C₈H₁₀NO₂S, is a compound that has garnered significant attention in the field of pharmaceutical and biochemical research. This compound, identified by its unique CAS number 406727-23-9, belongs to the class of thiazole derivatives, which are well-known for their diverse biological activities and potential therapeutic applications. The structural integrity of this molecule, featuring a thiazole ring substituted with a methyl group at the 4-position and an acetic acid ethyl ester at the 2-position, makes it a fascinating subject for further investigation.

The thiazole core is a heterocyclic compound that consists of a sulfur atom and a nitrogen atom embedded within a six-membered ring. This structural motif is widely recognized for its role in various biological processes and has been extensively studied for its pharmacological properties. The presence of the methyl group at the 4-position of the thiazole ring in Ethyl 2-(4-methylthiazol-5-yl)acetate introduces additional functional diversity, which can influence its interactions with biological targets. The ethyl ester group at the 2-position further enhances the compound's complexity and potential reactivity.

In recent years, there has been a surge in research focused on thiazole derivatives due to their broad spectrum of biological activities. These compounds have been investigated for their antimicrobial, anti-inflammatory, antioxidant, and anticancer properties. Specifically, Ethyl 2-(4-methylthiazol-5-yl)acetate has shown promise in preliminary studies as a potential lead compound for drug development. Its unique structural features suggest that it may interact with various biological targets, making it a valuable candidate for further exploration.

One of the most compelling aspects of Ethyl 2-(4-methylthiazol-5-yl)acetate is its potential role in modulating cellular pathways associated with cancer. Thiazole derivatives have been reported to inhibit the growth of tumor cells by interfering with key signaling pathways involved in cell proliferation and survival. For instance, studies have demonstrated that certain thiazole compounds can induce apoptosis in cancer cells while sparing healthy cells. Ethyl 2-(4-methylthiazol-5-yl)acetate may follow a similar mechanism, offering a new therapeutic strategy against cancer.

The compound's anti-inflammatory properties are another area of interest. Chronic inflammation is a hallmark of many diseases, including cancer, arthritis, and cardiovascular disorders. By targeting inflammatory pathways, Ethyl 2-(4-methylthiazol-5-yl)acetate could potentially mitigate symptoms associated with these conditions. Research has shown that thiazole derivatives can inhibit the production of pro-inflammatory cytokines, thereby reducing inflammation and related complications.

Furthermore, Ethyl 2-(4-methylthiazol-5-yl)acetate exhibits significant antioxidant activity. Oxidative stress plays a crucial role in the development of various diseases, including neurodegenerative disorders and aging-related conditions. The compound's ability to scavenge free radicals and protect cells from oxidative damage makes it a promising candidate for therapeutic applications. Studies have indicated that thiazole derivatives can enhance the activity of antioxidant enzymes and reduce oxidative stress-induced cellular damage.

The synthesis of Ethyl 2-(4-methylthiazol-5-yl)acetate involves multi-step organic reactions that require careful optimization to ensure high yield and purity. The process typically begins with the formation of the thiazole ring through condensation reactions involving sulfur-containing precursors. Subsequent modifications introduce the methyl group at the 4-position and the acetic acid ethyl ester at the 2-position. Advanced synthetic techniques, such as catalytic hydrogenation and nucleophilic substitution reactions, are often employed to achieve these transformations efficiently.

In terms of pharmacokinetics, Ethyl 2-(4-methylthiazol-5-yl)acetate must be evaluated for its absorption, distribution, metabolism, excretion (ADME), and toxicity (Tox). These parameters are critical for determining its suitability as a drug candidate. Preliminary studies have suggested that thiazole derivatives exhibit good oral bioavailability and rapid absorption after administration. However, further research is needed to fully understand their metabolic pathways and potential side effects.

The growing interest in Ethyl 2-(4-methylthiazol-5-yl)acetate underscores its potential as a versatile pharmacological agent. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in drug development efforts. Collaborative efforts between academic researchers and pharmaceutical companies will be essential to translate these findings into tangible therapeutic benefits for patients worldwide.

• 94159-31-6(2-(4-Methylthiazol-5-yl)ethyl butyrate)
• 98316-89-3(5-(2-methoxyethyl)-4-methyl-Thiazole)
• 656-53-1(4-Methyl-5-thiazolylethyl Acetate)
• 71929-24-3(4-Thiazoleacetic acid,5-(2-hydroxyethyl)-, methyl ester)
• 94159-32-7(2-(4-Methylthiazol-5-yl)ethyl Hexanoate)
• 102175-98-4(4-Methyl-5-thiazolylethanyl octanoate)
• 324742-96-3(2-(4-Methylthiazol-5-yl)ethyl propionate)
• 94159-30-5(2-(4-Methylthiazol-5-yl)ethyl valerate)
• 101426-31-7(2-(4-Methyl-5-thiazolyl)ethyl decanoate)
• 5255-33-4(2-(4-methyl-1,3-thiazol-5-yl)acetic acid)